2021 Pipeline Insights into Scleroderma – Key Players Include Corbus Pharmaceuticals, Gesynta Pharma and Formation Biologics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Scleroderma – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Scleroderma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of…
Details